Drug development for noise-induced hearing loss

Area of Science:

• Ototolaryngology
• Auditory Neuroscience
• Translational Medicine

Background:

• Noise-induced hearing loss (NIHL) is a significant global health issue, accounting for approximately 50% of non-genetic hearing impairment.
• Understanding the molecular mechanisms and pathology of NIHL is critical for developing effective therapeutic interventions.

Purpose of the Study:

• To review the complexities of human NIHL pathology.
• To examine experimental models used in studying NIHL mechanisms.
• To bridge the gap between basic science, preclinical studies, and clinical applications.

Main Methods:

• Comprehensive literature review of human NIHL pathology.
• Analysis of various experimental animal models for NIHL research.
• Inference and connection of findings across basic science, preclinical, and clinical studies.

Main Results:

• Experimental research has elucidated NIHL mechanisms, but methodological variations exist.
• Conflicting results between animal and human studies hinder data integration and clinical translation.
• Standardized exposure protocols and omics technologies are recommended for improved knowledge transfer.

Conclusions:

• Standardization of preclinical models is essential for advancing NIHL research.
• Identifying molecular targets is key to developing novel prevention and curative therapies for NIHL.
• Integrating findings from basic science to clinical practice requires methodological harmonization.